Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
PeterD. Friedmann, JeffreyA. Alexander, Yining Yey, Tammie Nahra, Soheil Soliman & HaroldA. Pollack. (2006) Duration of Nonmethadone Outpatient Treatment. Substance Abuse 27:3, pages 47-53.
Read now
Read now
KimberP. Richter. (2006) Good and Bad Times for Treating Cigarette Smoking in Drug Treatment. Journal of Psychoactive Drugs 38:3, pages 311-315.
Read now
Read now
Einat Peles, Mary
Jeanne Kreek, Scott Kellogg & Miriam Adelson. (2006) High Methadone Dose Significantly Reduces Cocaine Use in Methadone Maintenance Treatment (MMT) Patients. Journal of Addictive Diseases 25:1, pages 43-50.
Read now
Read now
Robert Mark McCool, Kimber Paschall Richter & Won S. Choi. (2005) Benefits of and Barriers to Providing Smoking Treatment in Methadone Clinics: Findings from a National Study. American Journal on Addictions 14:4, pages 358-366.
Read now
Read now
W.M. Wechsberg, B. Flannery, J.J. Kasten, C. Suerken, L. Dunlap, A.E. Roussel, L. Crum, O. Murdoch & H. Diesenhaus. (2004) Physicians Practicing in Methadone Treatment Programs. Journal of Addictive Diseases 23:2, pages 15-31.
Read now
Read now
Bruna Brands, Joan Blake & David Marsh. (2003) Impact of Methadone Program Philosophy Changes on Early Treatment Outcomes. Journal of Addictive Diseases 22:3, pages 19-38.
Read now
Read now
Jason Roy & Xihong Lin. (2002) Analysis of Multivariate Longitudinal Outcomes With Nonignorable Dropouts and Missing Covariates. Journal of the American Statistical Association 97:457, pages 40-52.
Read now
Read now
Articles from other publishers (41)
William C. Goedel, Aaron Shapiro, Magdalena Cerdá, Jennifer W. Tsai, Scott E. Hadland & Brandon D. L. Marshall. (2020) Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States. JAMA Network Open 3:4, pages e203711.
Crossref
Crossref
Jennifer M. Fenn, Jennifer S. Laurent & Stacey C. Sigmon. (2015) Increases in Body Mass Index Following Initiation of Methadone Treatment. Journal of Substance Abuse Treatment 51, pages 59-63.
Crossref
Crossref
Michal Abrahamowicz & Robyn Tamblyn. 2014. Wiley StatsRef: Statistics Reference Online. Wiley StatsRef: Statistics Reference Online.
Christina M. Andrews, Thomas A. D’Aunno, Harold A. Pollack & Peter D. Friedmann. (2013) Adoption of Evidence-Based Clinical Innovations. Medical Care Research and Review 71:1, pages 43-60.
Crossref
Crossref
Kaina Zhou & Guihua Zhuang. (2014) Retention in methadone maintenance treatment in mainland China, 2004–2012: A literature review. Addictive Behaviors 39:1, pages 22-29.
Crossref
Crossref
Alison Davie-Gray, Stephanie Moor, Carole Spencer & Lianne J. Woodward. (2013) Psychosocial characteristics and poly-drug use of pregnant women enrolled in methadone maintenance treatment. Neurotoxicology and Teratology 38, pages 46-52.
Crossref
Crossref
Ashley P. Kennedy, Karran A. Phillips, David H. Epstein, David A. Reamer, John Schmittner & Kenzie L. Preston. (2013) A randomized investigation of methadone doses at or over 100mg/day, combined with contingency management. Drug and Alcohol Dependence 130:1-3, pages 77-84.
Crossref
Crossref
Chau-kiu Cheung & Steven Sek-yum Ngai. (2013) Reducing youth's drug abuse through training social workers for cognitive–behavioral integrated treatment. Children and Youth Services Review 35:2, pages 302-311.
Crossref
Crossref
Jing Gu, Huifang Xu, Joseph T. F. Lau, Yuantao Hao, Ying Zhong, Lirui Fan, Yuteng Zhao, Chun Hao & Wenhua Ling. (2012) Misconceptions predict dropout and poor adherence prospectively among newly admitted first‐time methadone maintenance treatment clients in Guangzhou, China. Addiction 107:9, pages 1641-1649.
Crossref
Crossref
Brenda D. Smith & Irene T. Manfredo. (2011) Frontline counselors in organizational contexts: A study of treatment practices in community settings. Journal of Substance Abuse Treatment 41:2, pages 124-136.
Crossref
Crossref
A. Fassler & M. J. Naleppa. (2011) An Innovative Integrated Research Method: Estimating Fidelity Using Technology for Model Integration and Development. British Journal of Social Work 41:4, pages 761-777.
Crossref
Crossref
Nidal Moukaddam, David V. Herin, Angela Stotts, Anne Hamilton Dougherty, Charles Green, Marc Mooney, Ann Garcia, Richard A. Meisch, Katherine Cowan, Frederick Gerard Moeller, Joy M. Schmitz & John Grabowski. (2009) Comparison of 3 L-α-acetyl-methadol (LAAM) Maintenance Strategies for Heroin Dependence. Addictive Disorders & Their Treatment 8:4, pages 191-200.
Crossref
Crossref
Cynthia I. Campbell, Jeffrey A. Alexander & Christy Harris Lemak. (2009) Organizational determinants of outpatient substance abuse treatment duration in women. Journal of Substance Abuse Treatment 37:1, pages 64-72.
Crossref
Crossref
Lori J. Ducharme & Paul M. Roman. (2009) Opioid treatment programs in the Clinical Trials Network: Representativeness and buprenorphine adoption. Journal of Substance Abuse Treatment 37:1, pages 90-94.
Crossref
Crossref
Angela L. Stotts, Akihiko Masuda & Kelly Wilson. (2009) Using Acceptance and Commitment Therapy During Methadone Dose Reduction: Rationale, Treatment Description, and a Case Report. Cognitive and Behavioral Practice 16:2, pages 205-213.
Crossref
Crossref
Gerald Melnick, Harry K. Wexler, Michael Chaple & Charles M. Cleland. (2009) Constructive conflict and staff consensus in substance abuse treatment. Journal of Substance Abuse Treatment 36:2, pages 174-182.
Crossref
Crossref
Lori J Ducharme & Amanda J Abraham. (2008) State policy influence on the early diffusion of buprenorphine in community treatment programs. Substance Abuse Treatment, Prevention, and Policy 3:1.
Crossref
Crossref
Denise D. Routhier, Kenneth D. Katz & Daniel E. Brooks. (2007) QTc Prolongation and Torsades de Pointes Associated with Methadone Therapy. The Journal of Emergency Medicine 32:3, pages 275-278.
Crossref
Crossref
Ping Liu, Grover Foster, Robert LaBadie, Eugene Somoza & Amarnath Sharma. (2007) Pharmacokinetic Interaction between Voriconazole and Methadone at Steady State in Patients on Methadone Therapy. Antimicrobial Agents and Chemotherapy 51:1, pages 110-118.
Crossref
Crossref
Robert P. Schwartz, Jerome H. Jaffe, David A. Highfield, Jason M. Callaman & Kevin E. O’Grady. (2007) A randomized controlled trial of interim methadone maintenance: 10-Month follow-up. Drug and Alcohol Dependence 86:1, pages 30-36.
Crossref
Crossref
Dan Justo, Amir Gal‐Oz, Yael Paran, Yelena Goldin & David Zeltser. (2006) Methadone‐associated Torsades de Pointes (polymorphic ventricular tachycardia) in opioid‐dependent patients. Addiction 101:9, pages 1333-1338.
Crossref
Crossref
Harold A. Pollack, Thomas D'Aunno & Barbara Lamar. (2006) Outpatient substance abuse treatment and HIV prevention: An update. Journal of Substance Abuse Treatment 30:1, pages 39-47.
Crossref
Crossref
Thomas D’Aunno. (2005) Management Scholars and Public Policy: A Bridge Too Far?. Academy of Management Journal 48:6, pages 949-951.
Crossref
Crossref
Shabnam Lainwala, Elizabeth R. Brown, Nancy P. Weinschenk, Mary T. Blackwell & James I. Hagadorn. (2005) A RETROSPECTIVE STUDY OF LENGTH OF HOSPITAL STAY IN INFANTS TREATED FOR NEONATAL ABSTINENCE SYNDROME WITH METHADONE VERSUS ORAL MORPHINE PREPARATIONS. Advances in Neonatal Care 5:5, pages 265-272.
Crossref
Crossref
Kimber Richter, Won Choi & Daniel Alford. (2005) Smoking policies in U.S. outpatient drug treatment facilities. Nicotine & Tobacco Research 7:3, pages 475-480.
Crossref
Crossref
Michal Abrahamowicz & Robyn Tamblyn. 2005. Encyclopedia of Biostatistics. Encyclopedia of Biostatistics.
Duncan Stewart, Michael Gossop & John Marsden. (2004) Increased caseloads in methadone treatment programs: Implications for the delivery of services and retention in treatment. Journal of Substance Abuse Treatment 27:4, pages 301-306.
Crossref
Crossref
Carlos A. Albrecht. (2004) Proarrhythmia with Non-Antiarrhythmics. Cardiology 102:3, pages 122-139.
Crossref
Crossref
Jerry Flanzer. (2003) Health Services Research: Drug Use and Human Immunodeficiency Virus in the United States. Clinical Infectious Diseases 37:s5, pages S439-S444.
Crossref
Crossref
Fabrizio Faggiano, Federica Vigna-Taglianti, Elisabetta Versino & Patrizia Lemma. (2003) Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Michael Gossop, Duncan Stewart & John Marsden. (2003) Treatment process components and heroin use outcome among methadone patients. Drug and Alcohol Dependence 71:1, pages 93-102.
Crossref
Crossref
Peter D Friedmann, Stephenie C Lemon, Bradley J Anderson & Michael D Stein. (2003) Predictors of follow-up health status in the Drug Abuse Treatment Outcome Study (DATOS). Drug and Alcohol Dependence 69:3, pages 243-251.
Crossref
Crossref
Elizabeth M. Durkin. (2002) An Organizational Analysis of Psychosocial and Medical Services in Outpatient Drug Abuse Treatment Programs. Social Service Review 76:3, pages 406-429.
Crossref
Crossref
Dr Andrew Byrne. (2002) Commentary. Australian and New Zealand Journal of Public Health 26:4, pages 362-363.
Crossref
Crossref
Robert Heimer, Sarah Bray, Scott Burris, Kaveh Khoshnood & Kim M. Blankenship. (2002) Structural interventions to improve opiate maintenance. International Journal of Drug Policy 13:2, pages 103-111.
Crossref
Crossref
D.Dwayne Simpson. (2002) A conceptual framework for transferring research to practice. Journal of Substance Abuse Treatment 22:4, pages 171-182.
Crossref
Crossref
Chin B. Eap, Thierry Buclin & Pierre Baumann. (2002) Interindividual Variability of the Clinical Pharmacokinetics of Methadone. Clinical Pharmacokinetics 41:14, pages 1153-1193.
Crossref
Crossref
Deborah W Garnick, Dominic Hodgkin & Constance M Horgan. (2002) Selecting data sources for substance abuse services research. Journal of Substance Abuse Treatment 22:1, pages 11-22.
Crossref
Crossref
Christy Harris Lemak, Jeffrey A. Alexander & Thomas A. D’Aunno. (2016) Selective Contracting in Managed Care: The Case of Substance Abuse Treatment. Medical Care Research and Review 58:4, pages 455-481.
Crossref
Crossref
Sydney L. Hans & Rita J. Jeremy. (2001) Postneonatal mental and motor development of infants exposed in utero to opioid drugs. Infant Mental Health Journal 22:3, pages 300-315.
Crossref
Crossref
Jason Roy & Xihong Lin. (2000) Latent Variable Models for Longitudinal Data with Multiple Continuous Outcomes. Biometrics 56:4, pages 1047-1054.
Crossref
Crossref